80 related articles for article (PubMed ID: 15265548)
1. Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives.
Yokoi Y; Yonemochi E; Terada K
Int J Pharm; 2004 Aug; 280(1-2):67-75. PubMed ID: 15265548
[TBL] [Abstract][Full Text] [Related]
2. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension.
Yokoi Y; Yonemochi E; Terada K
Int J Pharm; 2005 Feb; 290(1-2):91-9. PubMed ID: 15664134
[TBL] [Abstract][Full Text] [Related]
3. A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities.
Ohta M; Buckton G
Int J Pharm; 2005 Jan; 289(1-2):31-8. PubMed ID: 15652196
[TBL] [Abstract][Full Text] [Related]
4. The use of inverse gas chromatography to assess the acid-base contributions to surface energies of cefditoren pivoxil and methacrylate copolymers and possible links to instability.
Ohta M; Buckton G
Int J Pharm; 2004 Mar; 272(1-2):121-8. PubMed ID: 15019075
[TBL] [Abstract][Full Text] [Related]
5. Determination of the changes in surface energetics of cefditoren pivoxil as a consequence of processing induced disorder and equilibration to different relative humidities.
Ohta M; Buckton G
Int J Pharm; 2004 Jan; 269(1):81-8. PubMed ID: 14698579
[TBL] [Abstract][Full Text] [Related]
6. Water vapor adsorption properties of amorphous cefditoren pivoxil evaluated by adsorption isotherms and microcalorimetry.
Ohta M; Tozuka Y; Oguchi T; Yamamoto K
Drug Dev Ind Pharm; 2000 Jun; 26(6):643-9. PubMed ID: 10826112
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
Iwai N; Nakamura H; Miyazu M; Watanabe Y
Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
[TBL] [Abstract][Full Text] [Related]
8. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H
Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of cefditoren pivoxil in non-infected adults.
Matsumoto K; Sato N; Mitomi N; Shitara Y; Shibasaki S
Jpn J Antibiot; 2014 Feb; 67(1):49-66. PubMed ID: 24809208
[TBL] [Abstract][Full Text] [Related]
11. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry.
Calahan JL; Azali SC; Munson EJ; Nagapudi K
Mol Pharm; 2015 Nov; 12(11):4115-23. PubMed ID: 26457879
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study on cefditoren pivoxil in pediatrics].
Satoh Y; Iwata S; Akita H; Aoyama T; Takeuchi Y; Yokota T; Sunakawa K
Jpn J Antibiot; 1993 Jul; 46(7):596-603. PubMed ID: 8371495
[TBL] [Abstract][Full Text] [Related]
14. [Physical ageing of amorphous polymeric excipients I. physicochemical principles].
Zelkó R; Kiss D
Acta Pharm Hung; 2005; 75(4):213-22. PubMed ID: 16711399
[TBL] [Abstract][Full Text] [Related]
15. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
Huang J; Wigent RJ; Schwartz JB
J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of cefditoren pivoxil in pediatric patients with infection.
Matsumoto K; Sato N; Mitomi N; Shibasaki S
Jpn J Antibiot; 2013 Dec; 66(6):357-75. PubMed ID: 24649799
[TBL] [Abstract][Full Text] [Related]
17. [Study of the crystalline behaviors of polymer by inverse gas chromatography].
Zou QC; Peng SJ; Fang GR; Yue XL
Se Pu; 2000 May; 18(3):202-5. PubMed ID: 12541555
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study on cefditoren pivoxil granules in the pediatric field].
Mori A; Meguro H; Terashima I; Fujii R
Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
[TBL] [Abstract][Full Text] [Related]
19. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
[TBL] [Abstract][Full Text] [Related]
20. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
